Functional ACE2 deficiency leading to angiotensin imbalance in the pathophysiology of COVID-19.
Joshua R Cook,John Ausiello +1 more
Reads0
Chats0
TLDR
In this paper, a review of the available data remains incomplete but are consistent with the possibility that the broad multisystem dysfunction of COVID-19 is due in large part to functional ACE2 deficiency leading to angiotensin imbalance with consequent immune dysregulation and endothelial cell dysfunction.Abstract:
SARS-CoV-2, the virus responsible for COVID-19, uses angiotensin converting enzyme 2 (ACE2) as its primary cell-surface receptor. ACE2 is a key enzyme in the counter-regulatory pathway of the broader renin-angiotensin system (RAS) that has been implicated in a broad array of human pathology. The RAS is composed of two competing pathways that work in opposition to each other: the "conventional" arm involving angiotensin converting enzyme (ACE) generating angiotensin-2 and the more recently identified ACE2 pathway that generates angiotensin (1-7). Following the original SARS pandemic, additional studies suggested that coronaviral binding to ACE2 resulted in downregulation of the membrane-bound enzyme. Given the similarities between the two viruses, many have posited a similar process with SARS-CoV-2. Proponents of this ACE2 deficiency model argue that downregulation of ACE2 limits its enzymatic function, thereby skewing the delicate balance between the two competing arms of the RAS. In this review we critically examine this model. The available data remain incomplete but are consistent with the possibility that the broad multisystem dysfunction of COVID-19 is due in large part to functional ACE2 deficiency leading to angiotensin imbalance with consequent immune dysregulation and endothelial cell dysfunction.read more
Citations
More filters
Journal ArticleDOI
Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets.
Masoumeh Farahani,Zahra Niknam,Leila Mohammadi Amirabad,Nasrin Amiri-Dashatan,Mehdi Koushki,Mohadeseh Nemati,Fahima Danesh Pouya,Mostafa Rezaei-Tavirani,Yousef Rasmi,Lobat Tayebi +9 more
TL;DR: In this article, a review of the possible mechanisms of the host response following SARS-CoV-2 infection and surveyed current research conducted by in-vitro, in vivo and human observations, as well as existing suggestions.
Journal ArticleDOI
Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets
TL;DR: In this paper , a review of the possible mechanisms of the host response following SARS-CoV-2 infection and surveyed current research conducted by in vitro, in vivo and human observations, as well as existing suggestions.
Journal ArticleDOI
Adipose tissue in COVID-19: detection of SARS-CoV-2 in adipocytes and activation of the interferon-alpha response
Alessio Basolo,Anello Marcello Poma,Diana Bonuccelli,Agnese Proietti,Elisabetta Macerola,Clara Ugolini,Liborio Torregrossa,Riccardo Giannini,P. Vignali,Fulvio Basolo,Ferruccio Santini,Antonio Toniolo +11 more
TL;DR: In this paper , the authors detected the SARS-CoV-2 genome in the adipose tissue of 13/23 (56%) cases of the COVID-19 cohort, showing that the virus may directly infect the parenchymal cells of subcutaneous fat.
Journal ArticleDOI
Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications
TL;DR: In this paper, the authors reviewed the clinical characteristics of COVID-19 associated endothelial dysfunction and the likely pathological mechanisms underlying the disease including direct cell entry or indirect immune overreactions after SARS-CoV-2 infection.
Journal ArticleDOI
Role of the Renin-Angiotensin-Aldosterone and Kinin-Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID.
Samantha Cooper,Eleanor Boyle,Sophie R. Jefferson,Calum R. A. Heslop,Pirathini Mohan,Gearry G. J. Mohanraj,Hamza A. Sidow,Rory C. P. Tan,Stephen J. Hill,Jeanette Woolard +9 more
TL;DR: In this article, the authors reviewed the impact of COVID-19 on the cardiovascular system, the mechanisms by which dysregulation of the RAAS and KKS can occur following virus infection and the future implications for pharmacological therapies.
References
More filters
Journal ArticleDOI
Neuropilin-1 maintains dimethylarginine dimethylaminohydrolase 1 expression in endothelial cells, and contributes to protection from angiotensin II–induced hypertension
Ying Wang,Enfeng Wang,Yuebo Zhang,Vijay Sagar Madamsetty,Baoan Ji,Derek C. Radisky,Joseph P. Grande,Sanjay Misra,Debabrata Mukhopadhyay +8 more
TL;DR: It is shown that N RP1 is required for full expression of DDAH1 in endothelial cells and that NRP1 contributes to protection from low‐dose angiotensin II–induced increases in blood pressure.
Journal ArticleDOI
Angiotensin II, III, and IV may be important in the progression of COVID-19.
TL;DR: Increasing ACE2 and Ang 1–7 may contribute to the treatment of hypertension and diabetes, two critical comorbidities of COVID-19, and the existence of alternative pathways for Ang II production and the increased Ang II levels even with blockage of the Ang type-1 receptor (AT1R) render the degradation steps of Ang II important.
Journal ArticleDOI
Glucocorticoids decrease the numbers and activation of mast cells by inducing the transactivation receptors of AGEs.
Tassia Santoro,Carolina Trindade de Azevedo,Patrícia M.R. e Silva,Marco A. Martins,Vinicius F. Carvalho,Vinicius F. Carvalho +5 more
TL;DR: It is concluded that the GC‐induced mastocytopenia and suppression of mast cell stimulation are associated with the gene transactivation of RAGE and galectin‐3.
Journal ArticleDOI
Aspirin downregulates angiotensin type 1 receptor transcription implications in capillary formation from endothelial cells.
Sona Mitra,Xianwei Wang,Magomed Khaidakov,Zufeng Ding,Srinivas Ayyadevera,Emily Hearnsberger,Tanu Goyal,Jawahar L. Mehta +7 more
TL;DR: It is suggested that ASA can inhibit Ang II–induced capillary formation in part via blocking NADPH oxidase and AT1R transcription, and the effect of ASA on newCapillary formation is mediated by its SA moiety.
Journal ArticleDOI
Glycosylated CD147 reduces myocardial collagen cross-linking in cardiac hypertrophy.
TL;DR: The hypertrophied left ventricle was progressively dilated in chronic pressure overload due to losing the limitation of collagen cross‐linking, and the compensated hypertrophy of left ventricularle gradually transited to congestive heart failure.